Image For Representation

Novavax begins clinical trial of Covid-19 vaccine in Australia

Sydney: US-based biotechnology company Novavax has started enrolling participants in Australia for a clinical trial of its coronavirus vaccine candidate, NVX-CoV2373. Preliminary immunogenicity and safety results from the Phase 1 portion of the trial are expected in July 2020, Novavax said on Monday. “Administering our vaccine in the first participants of this clinical trial is a […]